• Policy
• GSK's Shingrix has been granted
• by Lee, Tak-Sun Sep 8, 2021 06:05am

• Policy
• Roche’s Herceptin+Perjeta combo is approved in Korea
• by Lee, Tak-Sun Sep 7, 2021 05:53am

• Policy
• The request for Zolgensma's benefit is growing
• by Lee, Jeong-Hwan Sep 7, 2021 05:53am

• Policy
• Letrozole for ovulation-inducing use is not allowed
• by Lee, Hye-Kyung Sep 7, 2021 05:53am

• InterView
• Treatment-free remission drug for chronic myeloid leukemia
• by Sep 7, 2021 05:53am

• Company
• Tagrisso has established itself as an EGFR treatment
• by Sep 7, 2021 05:53am

• Company
• Downfall of Cialis·Viagra…market taken over by generics
• by Chon, Seung-Hyun Sep 6, 2021 05:59am

• Product
• Take Ibuprofen after Pfizer COVID vaccine??
• by Kim JiEun Sep 6, 2021 05:58am

• Policy
• Insurance benefit denied for 3 Soliris and 1 Ultomiris cases
• by Lee, Hye-Kyung Sep 6, 2021 05:58am

• Policy
• JAK Inhibitors increases heart attack
• by Lee, Tak-Sun Sep 6, 2021 05:58am